Friday, May 24, 2013 Last update: 7:08 AM
Company Tech News as it Breaks
Trade Events
AVEO Oncology
News articles for AVEO Oncology:
Wednesday, May 15, 2013
- AVEO and Astellas Announce Presentations of Tivozanib Clinical Data at 2013 American Society of Clinical Oncology Annual MeetingAVEO Oncology (NASDAQ: AVEO) and Astellas Pharma Inc. (TSE: 4503) today announced that additional data from the Phase 3 TIVO-1 trial (TIvozanib Versus sOrafenib ... read more
Thursday, May 2, 2013
- AVEO and Astellas Report FDA Oncologic Drug Advisory Committee Votes Tivozanib Application Did Not Demonstrate Favorable Benefit-to-Risk Evaluation in Treatment of Advanced Renal Cell CarcinomaAVEO Oncology (NASDAQ: AVEO) and Astellas Pharma Inc. (TSE: 4503) today reported that the U.S. Food and Drug Administration’s (FDA) Oncologic Drugs Advisory Committee (ODAC) voted that the ... read more
Monday, April 29, 2013
- AVEO Reports First Quarter 2013 Financial ResultsAVEO Oncology (NASDAQ: AVEO) today reported first quarter 2013 financial results. In lieu of a quarterly financial update conference call, the AVEO management team expects to host a ... read more
Wednesday, March 6, 2013
- AVEO Oncology to Present at the Barclays Global Healthcare ConferenceAVEO Oncology (NASDAQ: AVEO) today announced that David Johnston, chief financial officer, is scheduled to present at the Barclays Global Healthcare Conference on Wednesday, March 13, 2013 at ... read more
Wednesday, February 20, 2013
- AVEO Oncology to Present at the 2013 RBC Capital Markets’ Healthcare ConferenceAVEO Oncology (NASDAQ: AVEO) today announced that David Johnston, chief financial officer, is scheduled to present at the 2013 RBC Capital Markets’ Healthcare Conference on Wednesday, February 27, ... read more
Wednesday, February 13, 2013
- AVEO Reports 2012 Financial Results and Highlights Recent AccomplishmentsAVEO Oncology (NASDAQ: AVEO) today reported consolidated 2012 financial results and reviewed key recent accomplishments. “We continue to make significant progress ... read more
Thursday, January 31, 2013
- AVEO Oncology Announces Timing for Fourth Quarter and Year-End 2012 Financial Results Conference CallAVEO Oncology (NASDAQ:AVEO) today announced that financial results for the company’s fourth quarter and year ended December 31, 2012 will be released before the market opens on Wednesday, ... read more
Thursday, January 24, 2013
- AVEO Announces Closing of Public OfferingAVEO Pharmaceuticals, Inc. (NASDAQ: AVEO) today reported that it has closed its recently announced public offering of common stock. The total number of shares sold was 7,667,050, comprised ... read more
Wednesday, January 16, 2013
- AVEO Announces Proposed Public Offering of Common StockAVEO Pharmaceuticals, Inc. (NASDAQ: AVEO) today announced that it has commenced an underwritten public offering of shares of its common stock. All of the shares in the offering ... read more
Thursday, December 27, 2012
- AVEO Oncology to Present at the 31st Annual J.P. Morgan Healthcare ConferenceAVEO Oncology (NASDAQ: AVEO) today announced that Tuan Ha-Ngoc, president and chief executive officer, is scheduled to present at the 31st Annual J.P. Morgan Healthcare Conference on Tuesday, ... read more
Thursday, December 20, 2012
- AVEO Oncology Appoints Robert Epstein, M.D., M.S. to its Board of DirectorsAVEO Oncology (NASDAQ: AVEO) today announced the appointment of Robert Epstein, M.D., M.S. to its Board of Directors, and that Ronald A. DePinho, M.D. will retire from the ... read more
Monday, December 3, 2012
- AVEO and Astellas Announce Initiation of Patient Enrollment in Phase 2 Trial of Tivozanib in Combination with Paclitaxel in Patients with Advanced Triple Negative Breast CancerAVEO Oncology (NASDAQ: AVEO) and Astellas Pharma Inc. (TSE: 4503) today announced the initiation of patient enrollment in a randomized, double-blind, multicenter Phase 2 clinical trial, called BATON-BC, ... read more
Monday, November 26, 2012
- AVEO Oncology to Present at the Deutsche Bank 2012 dbAccess BioFEST ConferenceAVEO Oncology (NASDAQ: AVEO) today announced that David Johnston, chief financial officer, is scheduled to present at the Deutsche Bank 2012 dbAccess BioFEST Conference on Monday, December 3, ... read more